Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis.
Saved in:
| Title: | Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis. |
|---|---|
| Authors: | FitzGerald O; School of Medicine, UCD Conway Institute for Biomolecular Research, University College Dublin, Ireland., Behrens F; Translational Rheumatology, Immunology - Inflammation Medicine, University Hospital Goethe-University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany., Barton A; Centre for Musculoskeletal Research, the University of Manchester, Manchester, UK., Bertheussen H; GRAPPA Patient Research Partner, Norway., Boutouyrie-Dumont B; Novartis Institutes for BioMedical Research, Basel, Switzerland., Coates L; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Davies O; UCB Pharma, Slough, UK., de Wit M; GRAPPA Patient Research Partner, Zaltbommel, the Netherlands., Fagni F; Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany., Goodyear CS; School of Infection & Immunity, College of Medical, Veterinar & Life Sciences, University of Glasgow, Glasgow, UK., Gurke R; Pharmazentrum frankfurt/ZAFES, Institute of Clinical Pharmacology, Johann Wolfgang Goethe University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany., Hahnefeld L; Pharmazentrum frankfurt/ZAFES, Institute of Clinical Pharmacology, Johann Wolfgang Goethe University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany., Huppertz C; Novartis Institutes for BioMedical Research, Basel, Switzerland., Ioannidis V; Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Ibberson M; Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Katz A; GRAPPA Patient Research Partner, Israel., Klippstein M; Translational Rheumatology, Immunology - Inflammation Medicine, University Hospital Goethe-University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany., Koehm M; Translational Rheumatology, Immunology - Inflammation Medicine, University Hospital Goethe-University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany., Korish S; Bristol Myers Squibb, Princeton, NJ, USA., Mackay S; Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS, Sankt Augustin and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany., Martin DA; Pfizer Immunology & Inflammation Research Unit, Cambridge, MA, USA., O'Sullivan D; GRAPPA Patient Research Partner, Ireland., Patel K; Centre for Musculoskeletal Research, the University of Manchester, Manchester, UK., Rueping S; Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS, Sankt Augustin and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany., Schett G; Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany., Scholich K; Pharmazentrum frankfurt/ZAFES, Institute of Clinical Pharmacology, Johann Wolfgang Goethe University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany., Schwenk JM; Affinity Proteomics, Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden., Siebert S; School of Infection & Immunity, College of Medical, Veterinar & Life Sciences, University of Glasgow, Glasgow, UK., Simon D; Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany., Vivekanantham A; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK., Pennington SR; School of Medicine, UCD Conway Institute for Biomolecular Research, University College Dublin, Ireland. |
| Source: | Therapeutic advances in musculoskeletal disease [Ther Adv Musculoskelet Dis] 2023 Sep 08; Vol. 15, pp. 1759720X231192315. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101517322 Publication Model: eCollection Cited Medium: Print ISSN: 1759-720X (Print) Linking ISSN: 1759720X NLM ISO Abbreviation: Ther Adv Musculoskelet Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37694182 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22FitzGerald+O%22">FitzGerald O</searchLink>; School of Medicine, UCD Conway Institute for Biomolecular Research, University College Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Behrens+F%22">Behrens F</searchLink>; Translational Rheumatology, Immunology - Inflammation Medicine, University Hospital Goethe-University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Barton+A%22">Barton A</searchLink>; Centre for Musculoskeletal Research, the University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Bertheussen+H%22">Bertheussen H</searchLink>; GRAPPA Patient Research Partner, Norway.<br /><searchLink fieldCode="AU" term="%22Boutouyrie-Dumont+B%22">Boutouyrie-Dumont B</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Coates+L%22">Coates L</searchLink>; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Davies+O%22">Davies O</searchLink>; UCB Pharma, Slough, UK.<br /><searchLink fieldCode="AU" term="%22de+Wit+M%22">de Wit M</searchLink>; GRAPPA Patient Research Partner, Zaltbommel, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Fagni+F%22">Fagni F</searchLink>; Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Goodyear+CS%22">Goodyear CS</searchLink>; School of Infection & Immunity, College of Medical, Veterinar & Life Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Gurke+R%22">Gurke R</searchLink>; Pharmazentrum frankfurt/ZAFES, Institute of Clinical Pharmacology, Johann Wolfgang Goethe University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Hahnefeld+L%22">Hahnefeld L</searchLink>; Pharmazentrum frankfurt/ZAFES, Institute of Clinical Pharmacology, Johann Wolfgang Goethe University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Huppertz+C%22">Huppertz C</searchLink>; Novartis Institutes for BioMedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ioannidis+V%22">Ioannidis V</searchLink>; Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Ibberson+M%22">Ibberson M</searchLink>; Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Katz+A%22">Katz A</searchLink>; GRAPPA Patient Research Partner, Israel.<br /><searchLink fieldCode="AU" term="%22Klippstein+M%22">Klippstein M</searchLink>; Translational Rheumatology, Immunology - Inflammation Medicine, University Hospital Goethe-University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Koehm+M%22">Koehm M</searchLink>; Translational Rheumatology, Immunology - Inflammation Medicine, University Hospital Goethe-University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Korish+S%22">Korish S</searchLink>; Bristol Myers Squibb, Princeton, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Mackay+S%22">Mackay S</searchLink>; Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS, Sankt Augustin and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Martin+DA%22">Martin DA</searchLink>; Pfizer Immunology & Inflammation Research Unit, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22O'Sullivan+D%22">O'Sullivan D</searchLink>; GRAPPA Patient Research Partner, Ireland.<br /><searchLink fieldCode="AU" term="%22Patel+K%22">Patel K</searchLink>; Centre for Musculoskeletal Research, the University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22Rueping+S%22">Rueping S</searchLink>; Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS, Sankt Augustin and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Schett+G%22">Schett G</searchLink>; Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Scholich+K%22">Scholich K</searchLink>; Pharmazentrum frankfurt/ZAFES, Institute of Clinical Pharmacology, Johann Wolfgang Goethe University, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP and Fraunhofer Cluster of Excellence Immune Mediated Diseases, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Schwenk+JM%22">Schwenk JM</searchLink>; Affinity Proteomics, Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Solna, Sweden.<br /><searchLink fieldCode="AU" term="%22Siebert+S%22">Siebert S</searchLink>; School of Infection & Immunity, College of Medical, Veterinar & Life Sciences, University of Glasgow, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Simon+D%22">Simon D</searchLink>; Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.; Deutsches Zentrum für Immuntherapie (DZI), Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Vivekanantham+A%22">Vivekanantham A</searchLink>; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Pennington+SR%22">Pennington SR</searchLink>; School of Medicine, UCD Conway Institute for Biomolecular Research, University College Dublin, Ireland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101517322%22">Therapeutic advances in musculoskeletal disease</searchLink> [Ther Adv Musculoskelet Dis] 2023 Sep 08; Vol. 15, pp. 1759720X231192315. <i>Date of Electronic Publication: </i>2023 Sep 08 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Sage%22">Sage </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101517322 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1759-720X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221759720X%22">1759720X </searchLink><i>NLM ISO Abbreviation: </i>Ther Adv Musculoskelet Dis <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37694182 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1177/1759720X231192315 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1759720X231192315 Titles: – TitleFull: Application of clinical and molecular profiling data to improve patient outcomes in psoriatic arthritis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: FitzGerald O – PersonEntity: Name: NameFull: Behrens F – PersonEntity: Name: NameFull: Barton A – PersonEntity: Name: NameFull: Bertheussen H – PersonEntity: Name: NameFull: Boutouyrie-Dumont B – PersonEntity: Name: NameFull: Coates L – PersonEntity: Name: NameFull: Davies O – PersonEntity: Name: NameFull: de Wit M – PersonEntity: Name: NameFull: Fagni F – PersonEntity: Name: NameFull: Goodyear CS – PersonEntity: Name: NameFull: Gurke R – PersonEntity: Name: NameFull: Hahnefeld L – PersonEntity: Name: NameFull: Huppertz C – PersonEntity: Name: NameFull: Ioannidis V – PersonEntity: Name: NameFull: Ibberson M – PersonEntity: Name: NameFull: Katz A – PersonEntity: Name: NameFull: Klippstein M – PersonEntity: Name: NameFull: Koehm M – PersonEntity: Name: NameFull: Korish S – PersonEntity: Name: NameFull: Mackay S – PersonEntity: Name: NameFull: Martin DA – PersonEntity: Name: NameFull: O'Sullivan D – PersonEntity: Name: NameFull: Patel K – PersonEntity: Name: NameFull: Rueping S – PersonEntity: Name: NameFull: Schett G – PersonEntity: Name: NameFull: Scholich K – PersonEntity: Name: NameFull: Schwenk JM – PersonEntity: Name: NameFull: Siebert S – PersonEntity: Name: NameFull: Simon D – PersonEntity: Name: NameFull: Vivekanantham A – PersonEntity: Name: NameFull: Pennington SR IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 09 Text: 2023 Sep 08 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1759-720X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Therapeutic advances in musculoskeletal disease Type: main |
| ResultId | 1 |